Articles Posted in Featured

Published on:

We previously reported on Judge Sleet’s in limine rulings directed to Section 271(f) and European Patent Office proceedings in patent litigation related to aortic valve stents between Edwards Lifesciences and Medtronic Corevalve. After a jury trial last week, the jury awarded Edwards Lifesciences lost profit damages and reasonable royalties.

The verdict form has been made public and shows that the jury found direct infringement, willful infringement, infringement pursuant to Section 271(f), and that the patents-in-suit were valid. The jury awarded $388.8 million of lost profits and $4.8 million of reasonable royalty for infringing sales not subject to lost profits.

Continue reading

Posted in:
Published on:
Published on:

Delaware IP Law Blog Author, Greg Brodzik, and Contributor, Jim Lennon, were invited by to comment on the Supreme Court’s recent decision in Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al., 569 U.S. ___, on the scope of patent eligibility in the context of DNA discoveries. Follow this link to their post on Myriad: Positive Implications for Genetic Research, but Some Questions Remain Unanswered

Contact Information